Skip to main content

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA

Position in NVS — Novartis AG

CIK 932974 BOSTON, MA

Position in NVS

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$1,867,632
+$798,688 QoQ
Shares Held
11,917
+70.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#448
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $220,949,345 across 14 Drug Manufacturers - General names. NVS ranks #6 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NVS
Novartis AG
This page
11,917 $1,867,632

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,867,632 11,917
2026-03-31 $1,068,944 6,998
2025-12-31 $961,781 6,976
2025-09-30 $840,100 6,551
2025-06-30 $792,736 6,551
2025-03-31 $730,305 6,551
2024-12-31 $670,563 6,891
2024-09-30 $862,189 7,496
2024-06-30 $798,024 7,496
2024-03-31 $686,396 7,096
2023-12-31 $788,676 7,811
2023-09-30 $795,628 7,811
2023-06-30 $832,002 8,245
2023-03-31 $816,040 8,870
2022-12-31 $911,282 10,045
2022-09-30 $763,520 10,045
2022-06-30 $925,011 10,943
2022-03-31 $1,046,243 11,923
2021-12-31 $1,038,531 11,873
2021-09-30 $1,147,046 14,026
2021-06-30 $1,438,033 15,761
2021-03-31 $1,330,410 15,564
2020-12-31 $1,839,874 19,484
2020-09-30 $1,831,203 21,058
2020-06-30 $1,909,077 21,858
2020-03-31 $1,722,050 20,886